Return to Home

Masimo Corporation

MASI

Find Out if You Qualify for a Financial Reward by filling out the form below.

Lead Plaintiff Deadline:
October 23, 2023

Days Left:
-266

calendar

Masimo Corporation Form












Securities Fraud News does not share your information with others. There is no cost or obligation for you to submit.

Allegations

According to the complaint, defendants provided investors with material information concerning Masimo’s revenue and sales for the second quarter of fiscal 2023 and expected revenue for the full-year 2023. Defendants’ statements included, among other things, Masimo’s ability to deliver clinically proven new products to the healthcare markets thereby supporting defendants’ decision to forecast revenue of $550 million to $565 million for the quarter and increase its earnings-per-share estimates to between $3.59 per share and $3.69 per share. Defendants’ statements in this regard prompted an immediate and dramatic increase in the price of Masimo’s common stock. From a closing price of $167.31 per share on February 28, 2023 at the start of the Class Period, Masimo’s stock price climbed to $184.97 per share the following day on March 1, 2023 on unusually high volume. Defendants provided these overwhelmingly positive statements to investors while, at the same time, disseminating materially false and misleading statements and/or concealing material adverse facts. On July 17, 2023 Masimo issued a press release announcing its second quarter 2023 earnings. Defendants announced lower than expected revenue for the second quarter of fiscal 2023 and preliminarily decreased full-year revenue estimates for both healthcare and non-healthcare segments. On this news, the price of Masimo’s common stock declined dramatically. From a closing market price of $147.16 per share on July 17, 2023, Masimo’s stock price fell to $117.73 per share on July 18, 2023, a decline of nearly 20% in the span of just a single day.

Eligibility

In order to be included in the lawsuit, you must have incurred a loss on shares of Masimo purchased or acquired during the class period listed above.

Lead Plaintiff Deadline

If you suffered a loss in Masimo during the relevant time frame, you have until October 23, 2023 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

Find More Cases

Ticker Symbol Company Name Join Deadline
UNH UnitedHealth Group Inc. July 15, 2024 Join
TDOC Teladoc Health, Inc. July 16, 2024 Join
CMBM Cambium Networks Corporation July 22, 2024 Join
BIIB Biogen Inc. July 22, 2024 Join
FSLY Fastly, Inc. July 23, 2024 Join
ENPH Enphase Energy, Inc. July 29, 2024 Join
RIVN Rivian Automotive, Inc. July 30, 2024 Join
HTZ Hertz Global Holdings, Inc. July 30, 2024 Join
HUM Humana Inc. August 02, 2024 Join
MRNS Marinus Pharmaceuticals, Inc. August 05, 2024 Join
SMG The Scotts Miracle-Gro Company August 05, 2024 Join
GRTS Gritstone bio, Inc. August 06, 2024 Join
RBLX Roblox Corporation August 12, 2024 Join
TWOU 2U, Inc. August 12, 2024 Join
LW Lamb Weston Holdings, Inc. August 12, 2024 Join
TDC Teradata Corporation August 13, 2024 Join
NKE NIKE, Inc. August 19, 2024 Join
PATH UiPath, Inc. August 19, 2024 Join
FF FutureFuel Corp. August 23, 2024 Join
TM Toyota Motor Corporation August 23, 2024 Join
SRG Seritage Growth Properties August 30, 2024 Join
MDB MongoDB, Inc. September 09, 2024 Join
WBA Walgreens Boots Alliance, Inc. September 10, 2024 Join